Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22711,96,0.79 [0.43-1.44],0.4390906882854873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23324,173,1.01 [0.68-1.50],0.9455218763814262
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23098,1131,0.89 [0.76-1.05],0.1669335896313096
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23348,407,1.14 [0.90-1.45],0.2634186583975109
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22621,2949,0.92 [0.83-1.02],0.1103134567475726
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22836,2413,1.01 [0.91-1.12],0.8785450066857038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23114,1143,0.87 [0.74-1.03],0.0955861070442943
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23256,76,1.08 [0.61-1.92],0.79398688393267
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21808,671,0.86 [0.69-1.07],0.1816539836991755
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21078,775,0.93 [0.77-1.13],0.4865022540644045
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21123,214,0.87 [0.59-1.28],0.4786175863643862
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16352,1382,1.00 [0.87-1.15],0.948347812800176
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20938,315,1.11 [0.84-1.46],0.4665167599422504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23296,1325,0.92 [0.79-1.07],0.2715132198588202
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23399,458,1.13 [0.90-1.41],0.2895985588971992
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22766,799,0.90 [0.74-1.09],0.2863654470873039
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23353,738,0.88 [0.72-1.08],0.226156524017969
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22144,173,1.00 [0.68-1.49],0.9836720189143804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23457,37,1.03 [0.44-2.42],0.9447069187040302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23267,652,0.85 [0.68-1.06],0.1569369783462081
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23254,74,1.10 [0.63-1.94],0.7365718552553308
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23372,163,1.23 [0.86-1.75],0.2577965166809052
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23358,149,1.15 [0.78-1.70],0.4870456951749535
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22250,283,0.90 [0.65-1.24],0.5135808706624494
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22192,225,1.03 [0.74-1.45],0.8448000066255987
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22071,100,1.23 [0.78-1.93],0.3735554497507741
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23434,32,0.50 [0.15-1.68],0.263980054339749
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23390,139,0.76 [0.46-1.26],0.2911387610278022
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23290,39,0.70 [0.26-1.85],0.4696393619259236
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23321,70,0.68 [0.33-1.43],0.3122443928595217
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23214,200,1.23 [0.90-1.69],0.1940946109011638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23365,57,1.46 [0.89-2.41],0.1317242079961657
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23358,58,0.97 [0.49-1.93],0.9387708892432328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23204,1028,1.08 [0.92-1.26],0.355835265743009
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,23433,74,1.14 [0.66-1.95],0.6431026819619418
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,0.89 [0.43-1.83],0.754806625244332
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23426,114,0.84 [0.49-1.43],0.5126032400051911
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,1.20 [0.83-1.74],0.3408386153684939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23437,230,1.13 [0.82-1.55],0.4587246631166843
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23444,212,1.23 [0.91-1.67],0.1835675582585213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23377,56,1.25 [0.68-2.28],0.4703053824478151
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23442,130,0.80 [0.49-1.33],0.3969652695847493
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23403,237,0.97 [0.69-1.36],0.853380120828889
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23357,427,1.01 [0.78-1.30],0.9497502599394172
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23442,244,1.35 [1.03-1.77],0.0278911384205432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,0.78 [0.46-1.33],0.3618620254905939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.84 [0.51-1.35],0.4652808590533823
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19070,31,0.44 [0.13-1.51],0.1938156557429235
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19095,56,1.02 [0.52-2.03],0.946693569883013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23396,123,1.36 [0.95-1.96],0.093889802102589
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",23397,121,1.38 [0.97-1.99],0.0764322002370433
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,1.22 [0.99-1.50],0.0564139575730527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,16845,271,1.04 [0.75-1.46],0.8088556746095359
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Lymphoid leukaemia,19072,33,0.91 [0.35-2.36],0.8489562936796885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19191,152,0.75 [0.46-1.21],0.2414737758190021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19133,94,1.10 [0.66-1.82],0.7261744058056985
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,1.07 [0.73-1.58],0.7240687595683827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19099,60,0.89 [0.43-1.82],0.7398982761740105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19100,61,1.29 [0.72-2.29],0.3904174960692496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19088,49,1.57 [0.91-2.70],0.1021358334352895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,1.29 [0.87-1.91],0.206867260196155
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19128,89,0.79 [0.42-1.47],0.452594016822391
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19110,71,1.40 [0.86-2.27],0.1702164266537748
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19073,34,1.41 [0.70-2.82],0.3318538428282238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19109,70,1.10 [0.61-1.99],0.7545860995278333
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,23230,204,0.91 [0.62-1.33],0.6348062090817786
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23421,69,0.80 [0.40-1.61],0.5346221011525163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanoma in situ,19066,75,0.69 [0.34-1.40],0.300292683845195
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19108,69,0.98 [0.52-1.86],0.9610181506924164
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19168,129,0.98 [0.62-1.56],0.929125938807247
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19240,201,1.24 [0.89-1.75],0.2067254631764885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19119,80,0.96 [0.54-1.73],0.901232042594463
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,23264,149,1.23 [0.85-1.76],0.2680518394264841
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19827,788,0.94 [0.77-1.13],0.4935466525412317
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19862,823,0.91 [0.75-1.10],0.3343293009376506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23184,330,0.88 [0.65-1.19],0.4017467787067871
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21758,83,1.48 [0.99-2.22],0.054415081737852
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22922,68,0.92 [0.47-1.78],0.8008959475517705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22589,2521,0.95 [0.85-1.06],0.3341826477015409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22086,27,0.71 [0.22-2.31],0.5701411168035004
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23115,43,0.98 [0.44-2.16],0.950519638360954
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22956,1281,0.97 [0.84-1.13],0.7342591870013633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22956,1281,0.97 [0.84-1.13],0.7342591870013633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21741,66,1.17 [0.66-2.08],0.5902312747414873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23107,1048,0.98 [0.83-1.15],0.7696064116572893
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23173,101,1.33 [0.89-2.00],0.1616390411420338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22897,43,0.95 [0.42-2.14],0.8920183804248013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22906,52,1.27 [0.71-2.26],0.4214961592114459
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23270,198,0.97 [0.67-1.41],0.8792533688386245
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23362,53,0.68 [0.29-1.58],0.3709471432059107
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23240,168,1.01 [0.67-1.50],0.9786188750031896
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22171,112,0.63 [0.34-1.14],0.1277587199734817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18899,203,0.72 [0.47-1.10],0.1306754700436645
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22241,55,1.16 [0.54-2.48],0.7021681563991771
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22240,54,0.79 [0.32-1.93],0.5989285226969912
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18739,43,1.36 [0.72-2.54],0.3400188381486843
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21525,53,0.71 [0.30-1.66],0.4280509513230748
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21225,210,0.72 [0.47-1.09],0.1205726716868822
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23084,405,0.80 [0.60-1.07],0.1266672497304612
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22931,252,0.80 [0.56-1.16],0.2438158080154117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22737,58,0.93 [0.46-1.88],0.8350841138562767
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23133,1661,0.91 [0.80-1.04],0.1793050727612843
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20803,1624,0.92 [0.80-1.05],0.2110567781284612
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18743,47,1.38 [0.77-2.46],0.2767888680360033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20854,101,0.88 [0.51-1.53],0.6485397965106214
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,18940,244,0.96 [0.69-1.35],0.8293817098028633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18737,41,0.69 [0.26-1.79],0.4450016571123122
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21378,2682,0.97 [0.88-1.08],0.6168696729073968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18876,180,1.14 [0.80-1.62],0.4703951116680867
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19165,469,1.09 [0.87-1.37],0.4546464013392403
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23375,306,1.18 [0.91-1.54],0.2194101502539822
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23212,143,1.46 [1.07-2.00],0.0175128816620946
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18784,88,1.20 [0.74-1.94],0.4616083126681889
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18745,49,0.82 [0.36-1.86],0.6412710678632609
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22710,1957,0.99 [0.88-1.12],0.9077627608839745
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18867,171,0.86 [0.56-1.33],0.4965480826189679
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18864,168,0.99 [0.66-1.49],0.9515196846417798
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19153,457,0.93 [0.72-1.20],0.5882709080943059
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18764,68,0.76 [0.37-1.57],0.4613295542267814
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23206,137,1.36 [0.96-1.92],0.0848962500315706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19220,524,1.17 [0.96-1.43],0.1196690626926954
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19169,473,0.99 [0.78-1.26],0.9343266997782644
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21077,62,0.84 [0.41-1.73],0.6342153390814158
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22707,4011,1.01 [0.93-1.09],0.8334495985471994
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20815,62,0.79 [0.38-1.67],0.5423292978535534
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20830,77,1.06 [0.60-1.87],0.8468840852600947
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23294,1758,0.96 [0.85-1.10],0.5587527415151536
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23298,1757,0.96 [0.85-1.10],0.5654869232659997
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20824,71,0.75 [0.37-1.53],0.4271633186040966
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23104,1348,0.95 [0.82-1.10],0.4940309722791806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19971,1275,1.06 [0.92-1.21],0.4552421282535459
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23448,152,0.81 [0.51-1.31],0.3913133998129554
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22720,41,0.88 [0.37-2.11],0.773843096314031
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21871,115,0.82 [0.48-1.40],0.4681914560537016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21924,168,0.90 [0.59-1.37],0.619674206009506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18910,214,1.13 [0.81-1.56],0.4756538604995184
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21901,118,0.92 [0.56-1.52],0.7452814236963944
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1448,37,1.59 [0.74-3.44],0.2364875238249097
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1541,149,1.47 [1.01-2.13],0.0429210709051929
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21807,24,1.32 [0.55-3.16],0.534059852811789
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1432,22,0.89 [0.25-3.14],0.8593318686260041
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23053,1270,0.91 [0.78-1.06],0.2240985025113791
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22964,285,1.06 [0.79-1.42],0.7210979440915603
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21427,412,0.85 [0.65-1.12],0.2568609265615015
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19302,606,1.06 [0.87-1.30],0.5453366593878934
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23371,206,1.18 [0.85-1.63],0.3255644143056601
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22573,45,0.93 [0.41-2.10],0.8682492590339737
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22158,729,0.93 [0.76-1.13],0.4610648815175365
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22609,81,0.75 [0.38-1.47],0.4012998801615093
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22558,30,1.60 [0.85-3.02],0.1432346402142686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22666,138,1.17 [0.79-1.75],0.4371522036441436
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15241,1238,0.99 [0.85-1.14],0.8492866281670103
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,AV-block,20580,205,1.07 [0.75-1.50],0.7196877159080846
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23415,260,1.10 [0.81-1.49],0.5419713914665999
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14109,106,1.02 [0.63-1.64],0.9412864914572512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20495,120,0.79 [0.46-1.35],0.3822419514565137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20448,73,0.94 [0.50-1.76],0.8358246318704983
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23454,26,0.97 [0.63-1.50],0.9043064522213816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,20994,619,1.13 [0.93-1.36],0.2187517640344425
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22681,1261,0.99 [0.85-1.14],0.8556377186994546
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21106,6213,0.95 [0.89-1.02],0.1499816745346116
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22181,219,1.14 [0.82-1.57],0.4372612628987441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,20420,45,1.35 [0.74-2.46],0.3257740725536313
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23375,706,1.04 [0.86-1.26],0.6578370334964645
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,21636,5222,0.94 [0.88-1.01],0.1090658174745069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21644,5230,0.94 [0.88-1.02],0.1232965666172003
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23359,34,1.40 [0.69-2.82],0.346814922707393
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16562,148,0.90 [0.58-1.41],0.6504548219064266
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16479,65,0.61 [0.28-1.35],0.2226273634373825
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,23342,907,0.98 [0.82-1.16],0.7967015789590661
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22820,81,1.35 [0.86-2.14],0.1943288207323986
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22855,1426,0.97 [0.84-1.11],0.6371561616418566
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23192,382,1.01 [0.77-1.31],0.9648133054095026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20637,262,1.15 [0.86-1.53],0.3550693730870549
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23271,517,1.01 [0.80-1.27],0.9497572240217452
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21846,417,1.10 [0.87-1.40],0.4364502101426469
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23433,76,1.16 [0.67-2.00],0.5983060702907267
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23449,209,1.21 [0.88-1.66],0.2421835294817263
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21995,33,1.47 [0.76-2.85],0.2506832856026694
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22578,50,0.88 [0.40-1.92],0.7428696918372517
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20680,305,0.98 [0.73-1.32],0.8988604449420803
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22589,61,1.23 [0.69-2.20],0.4848933346165446
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22701,173,1.16 [0.81-1.67],0.4049156807766223
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20521,146,1.05 [0.69-1.60],0.8173880409052854
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22037,75,1.57 [1.04-2.38],0.0320775364077724
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22003,41,0.70 [0.27-1.82],0.4581351506872434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22403,32,0.67 [0.22-2.01],0.4748783793537019
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22092,130,1.01 [0.64-1.61],0.956323760417995
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21040,665,0.97 [0.79-1.19],0.7717481822132709
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22472,37,1.34 [0.69-2.59],0.3856789448665364
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22968,440,1.07 [0.84-1.36],0.5740153679467614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22957,278,0.77 [0.54-1.10],0.1535361499841122
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22824,453,0.79 [0.60-1.05],0.1001305788961541
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14251,248,1.05 [0.78-1.42],0.7288877317234745
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22761,243,1.07 [0.78-1.48],0.6611319907497131
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22246,284,1.10 [0.83-1.48],0.5009314053602887
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23056,377,0.93 [0.71-1.23],0.6238052913339973
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23387,491,1.26 [1.03-1.53],0.0226276316263354
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20557,182,1.33 [0.98-1.80],0.0704724641539098
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22951,272,0.81 [0.57-1.16],0.2442819496435286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22501,130,0.88 [0.54-1.43],0.6040424529925503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23183,444,1.02 [0.80-1.30],0.8661970505949615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23161,484,1.01 [0.80-1.27],0.9527685744780184
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22793,61,0.94 [0.47-1.89],0.8680631799964181
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22564,36,1.24 [0.60-2.54],0.5606152068114847
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22987,177,1.04 [0.71-1.52],0.8523918852256331
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22925,171,0.69 [0.43-1.11],0.1283535691634922
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,22335,373,1.03 [0.79-1.34],0.8259788058431499
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22538,82,1.11 [0.65-1.89],0.7141470282815705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23273,599,1.03 [0.84-1.27],0.7496518410657409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23420,192,1.18 [0.84-1.66],0.3434072553371968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20862,1575,0.93 [0.81-1.07],0.2963691812070235
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,22951,3664,0.94 [0.86-1.03],0.1856246512482063
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23394,224,1.16 [0.84-1.60],0.3574875808054704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20964,1677,0.91 [0.79-1.04],0.1619935519734972
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19364,77,1.42 [0.91-2.20],0.122540528623766
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,23110,1015,1.06 [0.89-1.25],0.5184251613553315
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20461,1174,1.03 [0.89-1.21],0.6670564047706027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,23043,91,0.76 [0.41-1.41],0.3810127276210576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23455,313,0.90 [0.66-1.23],0.5039845125808762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16087,51,0.52 [0.21-1.32],0.1718044286832386
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,21631,72,1.45 [0.93-2.26],0.1045372523945968
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22097,538,0.95 [0.75-1.19],0.652150876878135
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23111,187,1.07 [0.75-1.54],0.694033269308858
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23393,229,1.09 [0.79-1.51],0.601476373509026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23046,36,1.24 [0.59-2.60],0.5629289171476803
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23444,43,1.04 [0.48-2.23],0.9275065349230046
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22969,45,1.19 [0.61-2.34],0.6146511127188559
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,22212,236,0.79 [0.54-1.16],0.229784116774456
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23095,1119,1.00 [0.85-1.16],0.9609368015412892
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23412,300,0.63 [0.44-0.91],0.0135083592241508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22923,2449,1.03 [0.93-1.14],0.5395743995615226
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23147,40,0.90 [0.38-2.13],0.8043610157280328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,23346,182,1.01 [0.69-1.49],0.9620529222782234
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,22980,56,0.96 [0.47-1.98],0.9179883310115304
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23438,67,1.08 [0.59-1.96],0.8134548967798846
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21665,106,1.18 [0.76-1.85],0.4592617098047811
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21614,55,0.86 [0.40-1.84],0.6963842938066279
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Memory loss,22935,92,0.82 [0.45-1.49],0.5126768055057468
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,22409,433,1.01 [0.79-1.29],0.9431777195589895
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23359,393,0.94 [0.71-1.22],0.6258162089001811
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,16172,112,1.19 [0.79-1.81],0.4056300414314173
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23264,121,1.12 [0.71-1.74],0.6296102239191859
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22743,1184,0.88 [0.75-1.03],0.1182762456131368
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,22071,3143,0.87 [0.79-0.96],0.0063328024901726
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23132,122,0.79 [0.46-1.34],0.3844880700923583
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21920,361,0.72 [0.52-0.99],0.0443464540120425
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23408,196,0.98 [0.67-1.44],0.9269975785542408
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18981,558,0.89 [0.70-1.12],0.3079940297535865
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22981,57,0.75 [0.34-1.66],0.4768693401902385
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23032,108,1.36 [0.91-2.03],0.1360868224196791
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23251,139,0.56 [0.32-0.98],0.0422329144267792
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21639,80,1.33 [0.84-2.11],0.2254924767124852
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22045,69,1.08 [0.61-1.94],0.7880656868057861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23353,429,1.11 [0.88-1.41],0.3711878743044093
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22312,336,1.03 [0.78-1.37],0.838715679720444
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23433,141,0.61 [0.35-1.04],0.0704882708753017
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22995,71,1.47 [0.95-2.29],0.0838083053742056
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23454,75,0.63 [0.30-1.32],0.2219998041770259
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,272,1.24 [0.94-1.64],0.1305028288132511
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23245,33,0.73 [0.25-2.11],0.5588250362351732
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23445,136,1.20 [0.81-1.78],0.3543980734256329
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21616,57,0.48 [0.20-1.19],0.1141724892205952
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23455,316,0.88 [0.64-1.21],0.4373633245739466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23004,88,0.77 [0.41-1.45],0.4198362258888505
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22943,93,0.60 [0.31-1.18],0.1367534311934216
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23064,423,1.16 [0.93-1.46],0.1916210241960512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23331,141,0.97 [0.62-1.52],0.8965143538370917
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22502,51,1.49 [0.88-2.52],0.1344861850999401
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22498,47,0.89 [0.40-1.99],0.775665173997683
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23344,55,0.47 [0.19-1.20],0.1147347833646379
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23214,148,0.62 [0.37-1.05],0.073722264868349
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1439,28,1.23 [0.47-3.25],0.6775356563188162
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1727,54,1.11 [0.55-2.28],0.7657051483750307
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22934,84,1.30 [0.82-2.06],0.2564672913929522
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23307,896,1.15 [0.98-1.35],0.0790036993064734
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23093,642,1.14 [0.94-1.38],0.1808881701135806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22709,258,1.15 [0.86-1.55],0.3524092452244272
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23380,739,1.04 [0.86-1.25],0.7138321277899848
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23443,62,1.17 [0.65-2.12],0.592207822382035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23317,676,1.07 [0.88-1.29],0.5100825711652521
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23417,351,0.89 [0.66-1.19],0.4330525094348313
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23376,180,1.14 [0.81-1.62],0.4550859109204738
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22489,38,0.70 [0.45-1.09],0.1158395211015793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22492,41,0.82 [0.33-2.04],0.6757767646465873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22512,61,1.48 [0.91-2.42],0.114362360815239
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23381,609,1.09 [0.89-1.33],0.4047638622592441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22923,151,1.08 [0.73-1.61],0.6981523807415217
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22694,53,0.57 [0.23-1.40],0.2186675898247548
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23150,84,1.03 [0.60-1.78],0.9193897680914986
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23342,276,0.88 [0.63-1.23],0.4576067703612432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22824,183,0.98 [0.66-1.45],0.9221296662418478
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23312,116,0.96 [0.59-1.57],0.8734729976480466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23169,397,1.19 [0.95-1.50],0.1306699853134358
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22985,135,0.97 [0.62-1.52],0.8857421667191528
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21921,2165,1.09 [0.98-1.22],0.0997789700187042
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23308,242,0.80 [0.55-1.16],0.2456439134278026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23433,139,0.96 [0.61-1.50],0.8543818378138797
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22785,334,0.98 [0.73-1.31],0.8793528558575846
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23121,55,1.34 [0.78-2.28],0.2852096939501586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23430,49,1.33 [0.73-2.44],0.3549334379784841
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22532,81,1.05 [0.60-1.85],0.8529024162259331
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22579,128,0.98 [0.61-1.56],0.9217759194008572
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22498,87,1.28 [0.80-2.03],0.3052019477766177
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22695,54,0.99 [0.49-2.01],0.9871129823940684
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22465,54,0.92 [0.44-1.93],0.824736719807581
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22872,100,1.31 [0.86-2.01],0.2064140707618169
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22928,156,0.68 [0.41-1.12],0.1309573925092076
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22562,111,0.85 [0.49-1.45],0.5432644248319283
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22491,80,0.74 [0.38-1.45],0.381711528621406
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22467,56,1.13 [0.60-2.14],0.6996096709515416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21539,1783,1.04 [0.92-1.17],0.5619431252087224
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22528,77,0.96 [0.52-1.75],0.88531045922209
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23225,375,0.90 [0.68-1.19],0.4662269176961785
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22889,39,0.86 [0.35-2.13],0.739067647339714
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22998,148,0.92 [0.59-1.44],0.7260499079447733
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23237,99,0.70 [0.38-1.31],0.2661350868052866
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23415,94,1.05 [0.62-1.77],0.8540828889535925
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23351,122,0.80 [0.47-1.35],0.3974836047502255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23200,62,1.27 [0.73-2.21],0.3934719196369118
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23203,65,0.95 [0.49-1.84],0.8678541790906285
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23364,680,1.04 [0.86-1.26],0.6827437771980913
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23150,466,1.04 [0.82-1.31],0.7634194320609716
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22784,100,1.03 [0.61-1.72],0.9203230624616194
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22756,72,1.05 [0.58-1.89],0.880363137294232
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23212,75,1.36 [0.85-2.17],0.1958749550077508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23343,206,1.07 [0.75-1.51],0.7159055089794562
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23192,55,1.10 [0.56-2.14],0.7896580301173437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza,22017,108,0.93 [0.55-1.58],0.800987948681112
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22016,107,0.94 [0.55-1.59],0.8191920887567374
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16685,111,1.03 [0.64-1.67],0.8967099015595617
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23331,242,1.20 [0.89-1.60],0.2275209273214876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18210,1792,1.00 [0.89-1.13],0.999213844995
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18345,1771,1.00 [0.89-1.13],0.9736639828868976
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23107,114,1.18 [0.76-1.84],0.4505709203778475
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21970,61,1.14 [0.62-2.11],0.6660877531805699
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20256,345,1.10 [0.84-1.43],0.4857473090873486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19968,57,0.79 [0.36-1.73],0.5528644615861074
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22470,2559,1.06 [0.96-1.17],0.2504196218423815
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22359,56,0.37 [0.14-0.94],0.0370658756393544
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22426,123,1.00 [0.63-1.59],0.990128114007409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23306,886,1.17 [0.99-1.37],0.0609561107571942
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22368,65,0.50 [0.22-1.14],0.0977697773803654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21658,4386,1.00 [0.93-1.09],0.9137606426777258
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22596,293,0.77 [0.54-1.08],0.1337762917512952
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,22692,272,1.33 [1.00-1.75],0.0471814386473533
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Emphysema,20139,228,1.26 [0.91-1.76],0.1663377628508736
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22017,197,0.84 [0.56-1.26],0.3925731367229551
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23284,1375,0.99 [0.86-1.14],0.8944756070904615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22051,231,0.96 [0.67-1.36],0.8008653548552855
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,22664,614,1.11 [0.91-1.36],0.2868142519712505
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23449,180,0.74 [0.47-1.16],0.1947481700325637
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,22361,58,1.11 [0.59-2.08],0.7437825941593506
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23255,793,0.95 [0.78-1.15],0.581033786113556
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23294,1479,1.00 [0.88-1.15],0.9577171048106428
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22976,673,1.02 [0.84-1.24],0.8443697217163998
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,21849,34,0.64 [0.21-1.90],0.4172787092197035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23381,293,0.99 [0.73-1.34],0.9477004367089226
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23379,1005,1.00 [0.85-1.18],0.9892346961054328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,22518,703,1.06 [0.87-1.28],0.5627973824377701
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,21856,41,1.14 [0.56-2.31],0.7227918230062371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23076,1167,0.97 [0.83-1.13],0.6996038506301736
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23424,155,0.72 [0.44-1.18],0.195782291120252
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,21901,86,1.20 [0.73-1.98],0.4819553851237886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,23430,203,1.11 [0.79-1.55],0.5542752346083106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23142,54,1.26 [0.69-2.30],0.4587948680497388
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16618,44,1.26 [0.67-2.38],0.4791366215642584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23236,774,0.96 [0.79-1.16],0.6741125851294588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22545,242,1.19 [0.89-1.59],0.2475523977285567
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22091,182,1.21 [0.87-1.70],0.2603192198170898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23116,145,1.22 [0.84-1.79],0.2958507151060605
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11308,89,0.76 [0.40-1.42],0.3821836249879194
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16779,36,1.05 [0.45-2.49],0.9050964980733346
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23289,120,1.09 [0.70-1.71],0.6964825129285315
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,17614,72,0.67 [0.32-1.40],0.2849055365085214
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21502,140,0.98 [0.63-1.53],0.9255689029761112
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,22973,73,1.58 [1.03-2.42],0.034375800839467
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22714,30,0.72 [0.23-2.25],0.5744645291557486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,17839,297,1.14 [0.86-1.51],0.3538923985496167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21430,68,0.85 [0.43-1.69],0.6435006948456693
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23104,68,0.84 [0.42-1.68],0.6202604971049974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,21515,153,1.10 [0.74-1.63],0.6533470366776888
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22385,1023,1.10 [0.94-1.28],0.2361346258644952
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,17831,289,1.00 [0.73-1.36],0.9955830464835174
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21395,33,1.02 [0.42-2.49],0.9682188095014014
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23388,63,0.96 [0.49-1.88],0.896327334525942
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,22144,128,0.95 [0.59-1.51],0.8154340052956697
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,21838,95,1.25 [0.79-1.96],0.3433316389914559
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23333,134,1.09 [0.71-1.65],0.7036600066785319
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,23166,1453,0.87 [0.75-1.01],0.0652524429929097
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,21812,69,1.26 [0.74-2.14],0.3956314758956309
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23154,49,1.36 [0.75-2.45],0.3145485330615163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21816,73,1.01 [0.55-1.85],0.9870825703682088
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,22750,202,1.01 [0.71-1.45],0.9534711469088066
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22058,2092,1.05 [0.94-1.18],0.351457150765377
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23327,158,1.19 [0.82-1.71],0.3654935837536521
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,23372,688,1.17 [0.98-1.40],0.0901020027957073
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21490,3948,1.01 [0.93-1.09],0.8894172587438145
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23060,512,0.95 [0.75-1.20],0.6721733350622162
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23350,450,1.24 [1.00-1.53],0.0467964630504792
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22649,101,0.89 [0.51-1.55],0.6810493664327035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22521,55,1.17 [0.62-2.20],0.6216812357413088
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23203,1187,0.98 [0.85-1.15],0.8447624958123222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22526,89,1.20 [0.74-1.94],0.4694034527786235
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22723,1361,1.10 [0.96-1.26],0.15487947305868
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19480,2737,1.01 [0.91-1.11],0.8784218848924279
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17658,116,0.76 [0.43-1.32],0.3252604285355807
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23408,96,0.48 [0.24-0.95],0.0355123548593495
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23369,57,0.60 [0.26-1.38],0.2299866542989947
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22764,80,1.38 [0.88-2.18],0.1591682698968174
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16841,98,0.93 [0.54-1.60],0.7950195328162889
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18114,572,1.00 [0.80-1.25],0.99261438222593
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,17839,297,1.15 [0.87-1.53],0.3248060447962476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19929,2387,1.04 [0.94-1.16],0.4526205686688508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17951,409,1.05 [0.81-1.35],0.7132961623364394
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18365,7206,1.01 [0.95-1.07],0.7374887120111584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,22959,943,0.97 [0.82-1.15],0.7242377663294587
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22610,62,1.03 [0.54-1.95],0.938838707446677
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17577,1084,0.93 [0.79-1.09],0.3775506442447977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22716,32,1.23 [0.56-2.70],0.6073153696044111
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,22432,2466,1.04 [0.94-1.15],0.4204781225095148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,23377,52,0.63 [0.26-1.49],0.2923626545436261
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,16801,58,1.25 [0.70-2.24],0.4585393904661434
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20115,149,1.11 [0.75-1.65],0.5890843339347916
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16829,86,1.14 [0.69-1.89],0.6031614236501965
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22170,154,0.80 [0.50-1.27],0.3357240754988607
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17435,692,0.94 [0.76-1.15],0.5368179661514632
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23445,297,1.05 [0.78-1.42],0.7336342897866268
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22447,704,1.03 [0.85-1.25],0.7849068063834002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22683,940,0.98 [0.82-1.16],0.7836982505073863
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17674,132,0.99 [0.63-1.57],0.9768295568468948
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,18032,490,0.96 [0.76-1.23],0.7702119253914197
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23418,139,1.09 [0.72-1.65],0.6884870161120453
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20017,51,1.08 [0.53-2.21],0.8241669341435178
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17826,1083,0.94 [0.80-1.11],0.4918738626404167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21611,249,1.03 [0.75-1.43],0.8348857352027054
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21521,159,1.27 [0.90-1.79],0.1792392651496521
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18101,1358,1.11 [0.98-1.27],0.1078344160394951
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21606,4863,0.98 [0.91-1.06],0.6378493375453973
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22531,200,1.07 [0.75-1.51],0.7180822718018338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23258,574,1.12 [0.91-1.37],0.2797328083242861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18050,508,1.20 [0.97-1.47],0.0894578039986775
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21493,131,1.04 [0.67-1.62],0.8442533153482026
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23293,393,1.17 [0.92-1.48],0.1947600511103496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18475,933,1.00 [0.84-1.18],0.967263172391818
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22975,959,0.97 [0.82-1.15],0.7677457870042795
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22700,152,1.13 [0.77-1.66],0.5255987198971601
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18245,1502,0.89 [0.78-1.03],0.1261184001439024
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19334,1792,1.02 [0.90-1.15],0.7856508410185687
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22772,88,1.36 [0.88-2.11],0.1666771953803696
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22577,834,1.01 [0.85-1.21],0.8914101478355013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17026,283,0.98 [0.72-1.35],0.9216854750224608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23361,66,0.68 [0.32-1.44],0.313734615263718
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17167,424,1.05 [0.82-1.34],0.7165723065840868
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22134,118,1.16 [0.76-1.78],0.4849637322228675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23447,64,1.19 [0.66-2.12],0.5668954298761035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22550,116,1.27 [0.84-1.92],0.2491709914156071
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,21797,54,0.39 [0.15-1.02],0.0555606382840673
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17749,207,1.13 [0.80-1.59],0.4887101023650806
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,21880,137,0.83 [0.51-1.36],0.4632879852572901
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21856,113,0.91 [0.54-1.52],0.7101967850632876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20113,147,0.73 [0.44-1.21],0.2195725010271904
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16906,163,0.97 [0.64-1.48],0.8980838528686084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,20178,212,1.14 [0.82-1.58],0.4449367789749989
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Volvulus,16816,73,1.04 [0.58-1.89],0.8862982552186957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23381,214,1.12 [0.81-1.55],0.4916031981772586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23176,73,0.52 [0.24-1.14],0.1033829054836225
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21712,193,0.77 [0.50-1.17],0.2235569251232489
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22992,540,1.03 [0.82-1.28],0.8168713364546148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22580,128,1.43 [1.00-2.03],0.0470427806767219
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21786,267,1.09 [0.82-1.47],0.548722489494338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23183,243,0.91 [0.64-1.29],0.5892419994550647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23357,417,0.98 [0.75-1.26],0.854518382272177
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22982,42,0.61 [0.23-1.63],0.3207311547401758
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22078,2701,0.98 [0.89-1.09],0.7237404806509324
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23068,403,1.00 [0.78-1.29],0.9884929088620302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22941,276,1.10 [0.82-1.47],0.5218771668719031
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23179,727,1.05 [0.87-1.26],0.6372015821349711
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23436,67,0.91 [0.47-1.76],0.7841223357850355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21605,86,1.19 [0.73-1.93],0.4866271663490314
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22705,40,0.77 [0.30-1.96],0.5792963990789619
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23169,229,0.89 [0.62-1.29],0.5479681163797918
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21875,356,0.81 [0.60-1.10],0.1693642212524883
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21565,46,0.89 [0.40-2.02],0.7885376365567859
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23369,68,0.81 [0.40-1.64],0.5518483822448468
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22581,129,1.06 [0.68-1.65],0.7944134102033403
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23250,147,1.21 [0.83-1.77],0.3271123036215104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22982,42,0.67 [0.25-1.76],0.4162708609564979
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21573,54,0.75 [0.49-1.14],0.1829793885340409
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22870,1351,0.91 [0.78-1.05],0.1925101138947788
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21906,387,0.76 [0.56-1.03],0.075077246768187
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21567,48,1.13 [0.57-2.25],0.728771387619686
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23380,277,1.01 [0.74-1.38],0.961141747180452
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23014,74,1.24 [0.74-2.06],0.4165168914508715
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23316,213,1.03 [0.72-1.47],0.8737439810635421
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23407,240,1.18 [0.88-1.58],0.2798064090300083
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21660,141,0.72 [0.44-1.20],0.2124112344019247
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21742,223,1.02 [0.72-1.43],0.9266779831701872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23396,229,1.15 [0.84-1.56],0.3757204462740084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21686,167,1.13 [0.78-1.63],0.5287651144092103
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23426,125,1.03 [0.65-1.62],0.909612964251938
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20014,112,0.50 [0.27-0.95],0.0330587249735837
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21302,5467,1.02 [0.95-1.09],0.6171414960631223
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20124,4289,1.04 [0.96-1.12],0.3022012545091288
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19967,65,0.92 [0.47-1.79],0.8084640502509036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20128,133,1.18 [0.80-1.75],0.4003704980057386
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20177,182,0.90 [0.60-1.34],0.5938887968098103
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23213,98,1.25 [0.81-1.94],0.3093335327687889
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20096,101,0.48 [0.25-0.95],0.0357164756224768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17027,1192,1.09 [0.95-1.26],0.2079388515747869
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23319,198,1.04 [0.73-1.50],0.8195321370194302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20496,501,1.01 [0.80-1.27],0.9444702611678508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19703,6946,1.00 [0.94-1.06],0.9245958389023542
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21025,114,0.62 [0.34-1.14],0.1234904389122773
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20016,114,1.10 [0.69-1.75],0.6821606456183233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20494,592,1.09 [0.89-1.34],0.3850464484672226
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22575,2580,0.96 [0.86-1.06],0.4162418324167993
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20057,155,0.73 [0.45-1.19],0.2031418397690048
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20236,334,1.10 [0.84-1.44],0.4755055391661821
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20051,149,1.10 [0.74-1.64],0.6425125016153279
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22605,95,0.81 [0.45-1.46],0.4888618343578389
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17458,1623,1.01 [0.89-1.15],0.8265673358011849
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16015,180,0.92 [0.61-1.38],0.6818415834604703
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23443,177,0.98 [0.65-1.47],0.924086577931699
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15925,90,0.71 [0.38-1.35],0.3002672645402136
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16329,494,0.94 [0.74-1.19],0.589495840016012
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20192,290,1.09 [0.82-1.45],0.5466453862977811
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16388,553,0.99 [0.80-1.24],0.9607212928894064
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20053,58,1.54 [0.97-2.45],0.0697329637502523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20612,617,0.80 [0.63-1.01],0.0624328217068683
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20284,289,0.72 [0.51-1.03],0.073239512276914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16349,514,1.06 [0.85-1.32],0.591316016277107
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19975,73,0.89 [0.46-1.71],0.7247754669400021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19962,60,0.46 [0.19-1.10],0.0811176522893847
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20953,42,1.20 [0.60-2.40],0.5970771127402748
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23051,2140,0.97 [0.87-1.09],0.6018826963344783
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22456,1545,0.97 [0.85-1.11],0.7062027475993597
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23274,503,1.17 [0.95-1.44],0.1471217675588791
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18447,2612,1.06 [0.96-1.17],0.23788834174335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15896,61,0.71 [0.33-1.53],0.3819925244438025
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19991,89,1.35 [0.88-2.08],0.1667016632416983
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15877,42,1.42 [0.79-2.55],0.2461156206060036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16009,174,1.13 [0.79-1.61],0.5085379742261988
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21163,252,1.03 [0.75-1.41],0.8507397094623433
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21394,483,0.99 [0.78-1.25],0.90399602422531
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23431,93,1.33 [0.86-2.04],0.201112461009847
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21745,1750,0.92 [0.81-1.05],0.199085855300738
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20014,112,1.08 [0.68-1.71],0.7416622744166951
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16034,199,0.97 [0.67-1.40],0.8580186228924487
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20696,701,0.88 [0.72-1.09],0.2450404386409002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18023,2188,0.96 [0.85-1.07],0.4299305022094185
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22625,115,0.88 [0.52-1.47],0.6249989160397535
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23437,72,0.44 [0.20-1.00],0.0489721671525917
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19967,65,1.77 [1.19-2.63],0.0048618129322771
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21168,1266,1.05 [0.91-1.21],0.4878239827861339
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19970,68,1.05 [0.57-1.95],0.8767289856658032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17541,1706,0.97 [0.86-1.11],0.6817236976406689
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21034,123,0.94 [0.59-1.52],0.8102140068122915
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19951,49,0.49 [0.19-1.27],0.1440563274890914
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20164,169,1.02 [0.69-1.50],0.9391431351986628
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20392,490,1.08 [0.86-1.35],0.5007278975988085
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22955,445,1.01 [0.79-1.29],0.9191397488259104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20551,556,0.90 [0.72-1.14],0.3871142756711243
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23286,486,1.19 [0.97-1.46],0.1010502649985551
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23433,58,0.87 [0.41-1.82],0.7031309966713006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20096,194,1.38 [1.04-1.84],0.0270732844315004
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17957,782,0.88 [0.72-1.07],0.2002770566302746
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20472,570,1.03 [0.83-1.28],0.799868516035476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20008,106,0.78 [0.44-1.39],0.3924679406501187
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15906,71,1.28 [0.77-2.13],0.3386158095419401
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18097,2262,1.01 [0.91-1.12],0.8870772045137115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16557,722,0.86 [0.70-1.06],0.1583153138256764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22764,254,0.86 [0.60-1.22],0.3981789809225071
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23405,67,1.38 [0.84-2.28],0.1989981252368849
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21480,47,1.06 [0.52-2.16],0.8798906559985079
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15908,73,0.44 [0.20-0.99],0.0481894461862069
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20089,94,0.79 [0.43-1.44],0.4347220906680105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16342,507,1.15 [0.93-1.41],0.195751664762201
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20179,277,1.14 [0.85-1.51],0.3838787775074243
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20242,247,1.04 [0.76-1.43],0.7993729368639573
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20233,238,0.94 [0.67-1.33],0.7448525162897441
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18074,75,1.02 [0.57-1.82],0.9543866156826404
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23438,63,0.89 [0.44-1.80],0.7423196766665433
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20448,546,0.94 [0.74-1.18],0.5733038489909502
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22655,145,1.15 [0.78-1.70],0.4708475227447121
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22323,2421,1.00 [0.90-1.11],0.963350367538572
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20036,134,0.74 [0.44-1.25],0.2649779686370525
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20478,483,0.91 [0.71-1.17],0.4690642153765134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21955,218,0.95 [0.66-1.36],0.76049919486343
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20208,213,0.98 [0.68-1.40],0.9091856587677848
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21480,1485,0.95 [0.83-1.10],0.5104149370597958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21006,1011,1.01 [0.86-1.18],0.924222308500606
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19957,55,1.72 [1.14-2.60],0.0097064809013725
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22716,206,1.04 [0.73-1.47],0.8448070789763655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20073,171,1.07 [0.72-1.57],0.7451434726217032
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20016,114,0.88 [0.52-1.49],0.6311095290072157
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15877,42,1.55 [0.91-2.63],0.1068955878198034
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22627,1026,0.93 [0.78-1.10],0.3699371425150397
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,1.20 [0.73-1.97],0.4822282307935659
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,1.21 [0.77-1.92],0.4096315439050322
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23323,199,1.13 [0.81-1.58],0.4750285567020992
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23147,23,1.48 [0.67-3.26],0.3326126270417863
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22745,1144,0.97 [0.83-1.13],0.6806983321798005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23316,58,1.64 [1.05-2.57],0.031260951066804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23290,198,1.02 [0.71-1.48],0.8979011725405838
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20714,213,0.77 [0.51-1.15],0.1986859608278396
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,21646,45,1.19 [0.60-2.34],0.620101182084001
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,0.97 [0.71-1.33],0.856559019318887
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,1.09 [0.73-1.63],0.6819486509045913
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,1.05 [0.80-1.38],0.7078433819531296
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,1.07 [0.90-1.26],0.4597945112688202
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18201,4230,1.00 [0.93-1.09],0.9108553634645086
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23309,51,1.21 [0.65-2.27],0.5503018092042283
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21486,176,1.11 [0.77-1.59],0.5845620623151928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,1.13 [0.87-1.46],0.370969258914512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.74 [0.42-1.30],0.2961774570177643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,1.11 [0.83-1.49],0.488331659407652
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20568,67,0.78 [0.38-1.59],0.4970794206485066
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,1.05 [0.94-1.17],0.3866285425245265
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,0.85 [0.50-1.44],0.5428215766844919
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23446,56,0.44 [0.18-1.10],0.0805695490957979
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23446,65,0.86 [0.42-1.74],0.6714159886823928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22381,1880,1.01 [0.90-1.13],0.8965343311549367
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20907,406,0.87 [0.66-1.15],0.318919470045246
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,0.45 [0.23-0.91],0.0250635298756018
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23407,315,1.07 [0.80-1.41],0.6560092003694878
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23405,76,0.91 [0.49-1.69],0.7625195105036655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22106,1605,1.00 [0.88-1.14],0.9969661098942622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.17 [0.83-1.66],0.3775385520321634
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,1.29 [0.88-1.88],0.1905088053078897
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,1.21 [0.94-1.56],0.1365917018268883
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,0.77 [0.42-1.42],0.4085804486569337
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,0.97 [0.65-1.46],0.8949592629859675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21529,219,1.15 [0.84-1.58],0.3837944784281355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23194,102,0.93 [0.55-1.58],0.7881495539886827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.22 [0.92-1.62],0.1569835723166002
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,1.02 [0.58-1.77],0.9575645768058636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,1.02 [0.81-1.27],0.8769482435365065
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,1.15 [0.76-1.73],0.5116457075284875
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,1.01 [0.80-1.27],0.9516969871468473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23292,34,0.46 [0.14-1.52],0.2024875160528778
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23308,1998,0.97 [0.86-1.09],0.5587759094757789
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21453,143,1.05 [0.69-1.60],0.8226573712581943
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21678,77,0.91 [0.49-1.69],0.7603066244215091
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,1.08 [0.44-2.62],0.8671421345342074
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20627,126,1.34 [0.93-1.94],0.1155311702926513
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23353,229,1.14 [0.83-1.55],0.4214723697335356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,0.93 [0.57-1.53],0.7829198326578884
